HEADER TRANSFERASE 24-APR-23 8J63 TITLE THE CRYSTAL STRUCTURE OF TRKA KINASE IN COMPLEX WITH 4^6-METHYL-N-(3- TITLE 2 (4-METHYL-1H-IMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-11-OXO-5-OXA- TITLE 3 10,14-DIAZA-1(3,6)-IMIDAZO[1,2-B]PYRIDAZINA-4(1,3)- TITLE 4 BENZENACYCLOTETRADECAPHAN-2-YNE-4^5-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 5 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 6 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 7 P140-TRKA; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS EXPRESSION VECTOR PFASTBAC1-HM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 274590 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.M.ZHANG,Y.J.WANG REVDAT 2 11-OCT-23 8J63 1 JRNL REVDAT 1 20-SEP-23 8J63 0 JRNL AUTH Z.WANG,J.WANG,Y.WANG,S.XIANG,H.ZHOU,S.SONG,X.SONG,Z.TU, JRNL AUTH 2 Y.ZHOU,K.DING,Z.M.ZHANG,Z.ZHANG,X.LU JRNL TITL STRUCTURE-BASED OPTIMIZATION OF THE THIRD GENERATION TYPE II JRNL TITL 2 MACROCYCLE TRK INHIBITORS WITH IMPROVED ACTIVITY AGAINST JRNL TITL 3 SOLVENT-FRONT, XDFG, AND GATEKEEPER MUTATIONS. JRNL REF J.MED.CHEM. V. 66 12950 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37676745 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00899 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692+SVN REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.374 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 7383 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.969 REMARK 3 FREE R VALUE TEST SET COUNT : 736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 10.0000 - 5.1196 0.99 1373 158 0.2108 0.2692 REMARK 3 2 5.1196 - 4.0690 0.99 1334 140 0.1957 0.2467 REMARK 3 3 4.0690 - 3.5562 1.00 1330 147 0.2248 0.3153 REMARK 3 4 3.5562 - 3.2317 1.00 1306 141 0.2611 0.3103 REMARK 3 5 3.2317 - 3.0005 0.99 1304 150 0.2863 0.3478 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.372 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.839 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2360 REMARK 3 ANGLE : 0.790 3207 REMARK 3 CHIRALITY : 0.026 345 REMARK 3 PLANARITY : 0.003 407 REMARK 3 DIHEDRAL : 12.028 836 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 500 THROUGH 666 ) REMARK 3 ORIGIN FOR THE GROUP (A): -19.1645 -6.9759 -15.6711 REMARK 3 T TENSOR REMARK 3 T11: 0.2787 T22: 0.2643 REMARK 3 T33: 0.2490 T12: 0.0173 REMARK 3 T13: 0.0146 T23: 0.0441 REMARK 3 L TENSOR REMARK 3 L11: 4.5729 L22: 3.3966 REMARK 3 L33: 2.1055 L12: -2.0693 REMARK 3 L13: -0.9804 L23: 1.1795 REMARK 3 S TENSOR REMARK 3 S11: -0.0227 S12: 0.2771 S13: -0.2406 REMARK 3 S21: -0.0037 S22: -0.2307 S23: 0.3030 REMARK 3 S31: -0.0977 S32: -0.2539 S33: 0.1823 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 667 THROUGH 796 ) REMARK 3 ORIGIN FOR THE GROUP (A): 0.4094 -12.6684 -24.1123 REMARK 3 T TENSOR REMARK 3 T11: 0.2643 T22: 0.3950 REMARK 3 T33: 0.2621 T12: 0.1412 REMARK 3 T13: 0.0500 T23: 0.0217 REMARK 3 L TENSOR REMARK 3 L11: 2.3644 L22: 4.6759 REMARK 3 L33: 3.8992 L12: 2.5320 REMARK 3 L13: -0.9375 L23: -2.2502 REMARK 3 S TENSOR REMARK 3 S11: -0.0002 S12: -0.0163 S13: -0.2301 REMARK 3 S21: -0.1889 S22: -0.1338 S23: -0.1447 REMARK 3 S31: -0.0214 S32: -0.0145 S33: 0.2072 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8J63 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 10-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1300037269. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JAN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CAMD REMARK 200 BEAMLINE : GCPCC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7383 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA2HPO4/KH2PO4 (PH 6.2), 2M NACL, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 1 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -Y,-X,-Z+2/3 REMARK 290 5555 -X+Y,Y,-Z+1/3 REMARK 290 6555 X,X-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.05600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 152.11200 REMARK 290 SMTRY1 4 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 152.11200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 76.05600 REMARK 290 SMTRY1 6 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 498 REMARK 465 ASP A 499 REMARK 465 GLU A 535 REMARK 465 GLN A 536 REMARK 465 ASP A 537 REMARK 465 SER A 550 REMARK 465 GLU A 551 REMARK 465 LEU A 610 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 ARG A 554 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 555 CG CD OE1 NE2 REMARK 470 ARG A 559 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 568 CG CD OE1 NE2 REMARK 470 GLN A 570 CG CD OE1 NE2 REMARK 470 ARG A 593 CZ NH1 NH2 REMARK 470 LYS A 609 CG CD CE NZ REMARK 470 ASP A 674 CG OD1 OD2 REMARK 470 ARG A 686 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 702 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 GLN A 770 CG CD OE1 NE2 REMARK 470 LYS A 775 CG CD CE NZ REMARK 470 ASP A 776 CG OD1 OD2 REMARK 470 GLY A 796 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 513 -60.09 -98.80 REMARK 500 GLU A 581 98.30 -69.43 REMARK 500 HIS A 604 57.01 -144.51 REMARK 500 ALA A 608 77.07 57.30 REMARK 500 ARG A 649 -4.46 66.44 REMARK 500 ASP A 650 55.99 -150.26 REMARK 500 ILE A 675 2.03 59.25 REMARK 500 REMARK 500 REMARK: NULL DBREF 8J63 A 498 796 UNP P04629 NTRK1_HUMAN 498 796 SEQRES 1 A 299 SER ASP ALA CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE SEQRES 2 A 299 VAL LEU LYS TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS SEQRES 3 A 299 VAL PHE LEU ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN SEQRES 4 A 299 ASP LYS MET LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SEQRES 5 A 299 SER GLU SER ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU SEQRES 6 A 299 LEU LEU THR MET LEU GLN HIS GLN HIS ILE VAL ARG PHE SEQRES 7 A 299 PHE GLY VAL CYS THR GLU GLY ARG PRO LEU LEU MET VAL SEQRES 8 A 299 PHE GLU TYR MET ARG HIS GLY ASP LEU ASN ARG PHE LEU SEQRES 9 A 299 ARG SER HIS GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY SEQRES 10 A 299 GLU ASP VAL ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU SEQRES 11 A 299 LEU ALA VAL ALA SER GLN VAL ALA ALA GLY MET VAL TYR SEQRES 12 A 299 LEU ALA GLY LEU HIS PHE VAL HIS ARG ASP LEU ALA THR SEQRES 13 A 299 ARG ASN CYS LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE SEQRES 14 A 299 GLY ASP PHE GLY MET SER ARG ASP ILE TYR SER THR ASP SEQRES 15 A 299 TYR TYR ARG VAL GLY GLY ARG THR MET LEU PRO ILE ARG SEQRES 16 A 299 TRP MET PRO PRO GLU SER ILE LEU TYR ARG LYS PHE THR SEQRES 17 A 299 THR GLU SER ASP VAL TRP SER PHE GLY VAL VAL LEU TRP SEQRES 18 A 299 GLU ILE PHE THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SEQRES 19 A 299 SER ASN THR GLU ALA ILE ASP CYS ILE THR GLN GLY ARG SEQRES 20 A 299 GLU LEU GLU ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR SEQRES 21 A 299 ALA ILE MET ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN SEQRES 22 A 299 ARG HIS SER ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA SEQRES 23 A 299 LEU ALA GLN ALA PRO PRO VAL TYR LEU ASP VAL LEU GLY HET A6X A 801 48 HETNAM A6X 4^6-METHYL-N-(3-(4-METHYL-1H-IMIDAZOL-1-YL)-5- HETNAM 2 A6X (TRIFLUOROMETHYL)PHENYL)-11-OXO-5-OXA-10,14-DIAZA-1(3, HETNAM 3 A6X 6)-IMIDAZO[1,2-B]PYRIDAZINA-4(1,3)- HETNAM 4 A6X BENZENACYCLOTETRADECAPHAN-2-YNE-4^5-CARBOXAMIDE FORMUL 2 A6X C34 H31 F3 N8 O3 HELIX 1 AA1 LYS A 506 ARG A 508 5 3 HELIX 2 AA2 ALA A 553 LEU A 567 1 15 HELIX 3 AA3 ASP A 596 SER A 603 1 8 HELIX 4 AA4 GLY A 623 LEU A 644 1 22 HELIX 5 AA5 ALA A 652 ARG A 654 5 3 HELIX 6 AA6 GLY A 670 ASP A 674 5 5 HELIX 7 AA7 TYR A 676 TYR A 680 5 5 HELIX 8 AA8 PRO A 690 MET A 694 5 5 HELIX 9 AA9 PRO A 695 LEU A 700 1 6 HELIX 10 AB1 THR A 705 PHE A 721 1 17 HELIX 11 AB2 SER A 732 GLY A 743 1 12 HELIX 12 AB3 PRO A 753 TRP A 764 1 12 HELIX 13 AB4 GLU A 767 ARG A 771 5 5 HELIX 14 AB5 SER A 773 ALA A 787 1 15 HELIX 15 AB6 PRO A 788 ASP A 793 1 6 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 GLY A 522 CYS A 529 -1 O VAL A 524 N LEU A 516 SHEET 3 AA1 5 MET A 539 LEU A 546 -1 O VAL A 541 N ALA A 527 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 GLY A 659 0 SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O LYS A 665 N LEU A 657 SHEET 1 AA3 2 TYR A 681 VAL A 683 0 SHEET 2 AA3 2 THR A 687 LEU A 689 -1 O THR A 687 N VAL A 683 CISPEP 1 ALA A 500 CYS A 501 0 -0.47 CISPEP 2 LEU A 533 PRO A 534 0 -2.45 CISPEP 3 ARG A 583 PRO A 584 0 2.01 CISPEP 4 GLY A 605 PRO A 606 0 -6.78 CISPEP 5 ASP A 607 ALA A 608 0 2.96 CISPEP 6 PHE A 669 GLY A 670 0 3.85 CISPEP 7 PRO A 749 ARG A 750 0 -2.79 CRYST1 52.125 52.125 228.168 90.00 90.00 120.00 P 31 1 2 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019185 0.011076 0.000000 0.00000 SCALE2 0.000000 0.022153 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004383 0.00000